A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer.

被引：0
|
作者：
Chua, Melvin
Murgic, Jure
Hosni, Ali
Salcedo, Adriana
Kamel-Reid, Suzanne
Berlin, Alejandro
Pintile, Melania
Fraser, Michael
Van Der Kwast, Theodorus
Boutros, Paul Christopher
Bristow, Robert G.
机构：
[1] Natl Canc Ctr Singapore, Singapore, Singapore
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Ontario Inst Canc Res, Toronto, ON, Canada
[4] Univ Hlth Network, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Toronto, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON, Canada
[7] Manchester Canc Res Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.68
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Biopsy Based Genomic Classifier Predicts Biochemical Failure and Metastasis after Definitive Radiation without Hormone Therapy in a Prospective Cohort of Intermediate-Risk Prostate Cancer
    Chua, M. L. K.
    Bristow, R. G.
    Murgic, J.
    Abdalaty, A. Hosni
    Salcedo, A.
    Kamel-Reid, S.
    Fraser, M.
    Zhang, J.
    Wang, Q.
    Ch'ng, C.
    Deheshi, S.
    Davicioni, E.
    Van der Kwast, T.
    Boutros, P.
    Berlin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S99 - S99
  • [2] Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
    Nguyen, P. L.
    Martin, N. E.
    Choeurng, V.
    Palmer-Aronsten, B.
    Kolisnik, T.
    Beard, C. J.
    Orio, P. F.
    Nezolosky, M. D.
    Chen, Y-W
    Shin, H.
    Davicioni, E.
    Feng, F. Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (02) : 186 - 192
  • [3] Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
    P L Nguyen
    N E Martin
    V Choeurng
    B Palmer-Aronsten
    T Kolisnik
    C J Beard
    P F Orio
    M D Nezolosky
    Y-W Chen
    H Shin
    E Davicioni
    F Y Feng
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 186 - 192
  • [4] The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer
    Nguyen, P. L.
    Martin, N. E.
    Palmer-Aronsten, B. J.
    Choeurng, V.
    Kolisnik, T.
    Beard, C. J.
    Nezolosky, M. D.
    Chen, Y. W.
    Shin, H.
    Davicioni, E.
    Feng, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S113 - S114
  • [5] Intermediate risk prostate cancer: Prognostic factors predicting biochemical control after definitive radiation therapy with or without hormonal therapy
    Hannoun-Levi, J.
    Salem, N.
    Azria, D.
    Chamorey, C.
    Moro, M.
    Cowen, D.
    Muracciole, X.
    Teissier, E.
    Ellis, S.
    Pietra, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S56 - S57
  • [6] Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
    Den, Robert B.
    Feng, Felix Y.
    Showalter, Timothy N.
    Mishra, Mark V.
    Trabulsi, Edouard J.
    Lallas, Costas D.
    Gomella, Leonard G.
    Kelly, W. Kevin
    Birbe, Ruth C.
    Mccue, Peter A.
    Ghadessi, Mercedeh
    Yousefi, Kasra
    Davicioni, Elai
    Knudsen, Karen E.
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (05): : 1038 - 1046
  • [7] Validation of a genomic classifier for predicting biochemical failure following postoperative radiation therapy in high-risk prostate cancer
    Den, Robert Benjamin
    Feng, Felix Yi-Chung
    Showalter, Timothy Norman
    Mishra, Mark Vikas
    Trabulsi, Edouard John
    Lallas, Costas D.
    Gomella, Leonard G.
    Birbe, Ruth C.
    Mccue, Peter
    Ghadessi, Mercedeh
    Knudsen, Karen E.
    Dicker, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Intermediate-risk profile in prostate cancer. Role of combined radiation and hormone therapy
    Beck, Marcus
    Boehmer, Dirk
    Hoecht, Stefan
    Zschaeck, Sebastian
    Budach, Volker
    Wiegel, Thomas
    Ghadjar, Pirus
    ONKOLOGE, 2019, 25 (04): : 322 - 329
  • [9] Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy
    Berlin, Alejandro
    Murgic, Jure
    Hosni, Ali
    Pintilie, Melania
    Salcedo, Adriana
    Fraser, Michael
    Kamel-Reid, Suzanne
    Zhang, Jingbin
    Wang, Qiqi
    Ch'ng, Carolyn
    Deheshi, Samineh
    Davicioni, Elai
    van der Kwast, Theodorus
    Boutros, Paul C.
    Bristow, Robert G.
    Chua, Melvin L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (01): : 84 - 91
  • [10] Percentage of positive biopsy cores to predict distant metastasis of prostate cancer after definitive radiation therapy
    Huang, J.
    Kestin, L. L.
    Vicini, F. A.
    Williams, S. G.
    Ye, H.
    McGrath, S. D.
    Ghilezan, M.
    Martinez, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
12345